IG group | SPS group | SZC group | IG + SZC group | P | |
---|---|---|---|---|---|
Serum potassium before treatment, M (Q1, Q3) | 5.85 (5.64,6.09) | 5.96 (5.70,6.24) | 6.01 (5.74,6.27) | 6.56 (6.37,7.08) | < 0.001a |
Serum potassium after treatment M (Q1, Q3) | 5.20c (4.90,5.49) | 5.38c (5.27,6.07) | 5.32c (5.00,5.74) | 5.30c (4.65,5.53) | 0.016b |
Decrease of serum potassium | 0.71 ± 0.32 | 0.43 ± 0.38 | 0.64 ± 0.36 | 1.43 ± 0.38 | < 0.001a |
Dispersion coefficient (CV) of serum potassium decline | 45% | 89.3% | 56.8% | 26.9% | |
The rate of serum potassium decline (%) | 11.89 ± 5.19 | 7.12 ± 6.32 | 10.58 ± 6.07 | 21.51 ± 5.74a | < 0.001 |
The standard-reaching rate of serum potassium (cases/%) | 35 (76.1%) | 19 (57.6%) | 21 (55.3%) | 15 (68.2%) | 0.176 |
Control rate of severe hyperkalemia (cases/%) | 7 (100%) | 6 (60%) | 11 (91.7%) | 18 (100%) | 0.135d |